Top Pharmaceuticals companies in Saudi Arabia by Revenue

This ranking features the top 13 Pharmaceuticals companies in Saudi Arabia ranked by Revenue, totalling a Revenue of USD 11.34 B, for January 15, 2025.
#
Name
Revenue
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD 2.53 B
Dec. 31, 2023 USD 79.48 0.76%

Saudi Arabia

2
USD 2.32 B
Dec. 31, 2023 USD 31.76 1.20%

Saudi Arabia

3
USD 1.53 B
Dec. 31, 2023 USD 20.64 1.45%

Saudi Arabia

4
USD 1.29 B
Dec. 31, 2023 USD 2.55 1.28%

Saudi Arabia

5
USD 783.58 M
Dec. 31, 2023 USD 41.76 2.90%

Saudi Arabia

6
USD 761.10 M
Dec. 31, 2023 USD 53.63 2.87%

Saudi Arabia

7
USD 720.37 M
Dec. 31, 2023 USD 23.52 1.86%

Saudi Arabia

8
USD 440.15 M
Dec. 31, 2023 USD 8.71 -2.08%

Saudi Arabia

9
USD 371.89 M
Dec. 31, 2023 USD 9.94 0.96%

Saudi Arabia

10
USD 313.33 M
Dec. 31, 2023 USD 11.16 0.61%

Saudi Arabia

11
USD 197.33 M
Dec. 31, 2023 USD 8.51 -0.30%

Saudi Arabia

12
USD 66.60 M
Dec. 31, 2023 USD 23.81 0.35%

Saudi Arabia

13
USD 16.33 M
Dec. 31, 2023 USD 15.96 0.01%

Saudi Arabia

Frequently Asked Questions
  • Which Pharmaceuticals company in Saudi Arabia has the highest Revenue ?

    The Pharmaceuticals company in Saudi Arabia with the highest Revenue is Dr. Sulaiman Al Habib Medical Services Group Company (Saudi Stock Exchange: 4013.SR) at USD 2.53 B.

  • Which Pharmaceuticals company in Saudi Arabia has the lowest Revenue ?

    The Pharmaceuticals company in Saudi Arabia with the lowest Revenue is Al-Razi Medical Co. (Saudi Stock Exchange: 9572.SR) at USD 16.33 M.